Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 25, Issue 2, 2005, Pages 181-191

  García López, Elvia ^a   Anderstam, Björn ^a   Heimbürger, Olof ^a   Amici, Gianpaolo ^b   Werynski, Andrzej ^c   Lindholm, Bengt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OSPEDALE CA FONCELLO   (Italy)

^c INSTITUTE OF BIOCYBERNETICS AND BIOMEDICAL ENGINEERING   (Poland)

Author keywords

Gel filtration HPLC; Icodextrin; Maltose; Amylase activity

Indexed keywords

AMYLASE; DIANEAL; DRUG METABOLITE; EXTRANEAL; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLUCOSE; ICODEXTRIN; MALTOSE; MALTOTRIOSE;

ADULT; AGED; ARTICLE; CARBOHYDRATE ANALYSIS; DIALYSATE; DRUG DETERMINATION; ENZYME ACTIVITY; FEMALE; GEL FILTRATION CHROMATOGRAPHY; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PERITONEAL DIALYSIS; PLASMA; PRIORITY JOURNAL;

EID: 16844380850     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080502500213     Document Type: Article

References (31)

1. Alsop RM. History, chemical and pharmaceutical development of icodextrin. Perit Dial Int 1994; 14(Suppl 2): S5-12.
2. Davies DS. Kinetics of icodextrin. Perit Dial Int 1994; 14(Suppl 2):S45-50.
3. Krediet RT. The physiology of peritoneal solute transport and ultrafiltration. In: Gokal R, Khanna R, Krediet RT, Nolph KD, eds. Textbook of Peritoneal Dialysis. 2nd ed. Amsterdam: Kluwer Academic Publishers; 2000: 135-72.
4. Mistry CD, Mallick NP, Gokal R. Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges. Lancet 1987; 2(8552):178-82.
5. Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 1994; 46:496-503.
6. Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ, Hiralall JK, de Waart DR, Struijk DG, et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50:979-86.
7. Moberly JB, Mujais S, Gehr T, Hamburger R, Sprague S, Kucharski A, et al. Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int Suppl 2002; 81: S23-33.
8. Heimburger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992; 41:1320-32.
9. Posthuma N, ter Wee PM, Donker AJ, Oe PL, van Dorp W, Peers EM, et al. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell. Perit Dial Int 1997; 17:602-7.
10. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, et al. Efficacy and safety of a 7.5% icodextrin Peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002; 39:862-71.
11. Anderstam B, Garcia-Lopez E, Heimburger O, Lindholm B. Determination of alpha-amylase activity in serum and dialysate from patients using icodextrin-based peritoneal dialysis fluid. Perit Dial Int 2003; 23:146-50.
12. Posthuma N, ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, et al. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant 1997; 12:550-3.
13. Woodrow G, Stables G, Oldroyd B, Gibson J, Turney JH, Brownjohn AM. Comparison of icodextrin and glucose solutions for the daytime dwellin automated peritoneal dialysis. Nephrol Dial Transplant 1999; 14:1530-5.
14. de Boer AW, Schroder CH, van Vliet R, Willems JL, Monnens LA. Clinical experience with icodextrin in children: ultrafiltration profiles and metabolism. Pediatr Nephrol 2000; 15(1-2):21-4.
15. MacGinley R, Cooney K, Alexander G, Goldsmith D. A large single centre experience of 154 patients using icodextrin for peritoneal dialysis [Abstract]. J Am Soc Nephrol 2001; 12:313A.
16. Wolfson M, Piraino B, Hamburger RJ, Morton AR. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40:1055-65.
17. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-44.
18. Burke RA, Hvizd MG, Shockley TR. Direct determination of polyglucose metabolites in plasma using anion-exchange chromatography with pulsed amperometric detection. J Chromatogr B Biomed Sci Appl 1997; 693:353-7.
19. Burke RA, Shockley TR. Quantitation of dextran 70 in peritoneal dialysate from patients administered 7.5% polyglucose. J Chromatogr B Biomed Sci Appl 1998; 718: 115-20.
20. Kennedy JF, Fox JE. Fully automatic gel-permeation chromatographic analysis of neutral oligosaccharides. In: Whistler RL, BeMiller JN eds. Methods in Carbohydrate Chemistry. New York: Academic Press; 1980: 13-19.
21. Wang R, Moberly JB, Martis L, Shockley TR, Mongoven JW, Patel H, et al. A rapid assay for icodextrin determination in plasma and dialysate. Adv Perit Dial 2002; 18:91-5.
22. Feriani M, Catizone L, Fracasso A. Peritoneal dialysis solutions and systems. In: Gokal R, Khanna R, Krediet RT, Nolph KD, eds. Textbook of Peritoneal Dialysis. 2nd ed. Amsterdam: Kluwer Academic Publishers; 2000: 254-305.
23. Mistry CD. Glucose polymer as an osmotic agent in continuous peritoneal dialysis [Thesis]. London: University of London; 1989.
24. Bredie SJ, Bosch FH, Demacker PN, Stalenhoef AF, van Leusen R. Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit Dial Int 2001; 21:275-81.
25. Rippe B, Levin L. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD. Kidney Int 2000; 57:2546-56.
26. Burke RA, Moberly JB, Patel H, Shockley TR, Martis L. Maltose and isomaltose in uremic plasma following icodextrin administration. Adv Perit Dial 1998; 14:120-3.
27. Waniewski J, Wang T, Heimburger O, Werynski A, Lindholm B. Discriminative impact of ultrafiltration on peritoneal protein transport. Perit Dial Int 2000; 20:39-46.
28. de Waart DR, Zweers MM, Struijk DG, Krediet RT. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality. Perit Dial Int 2001; 21:269-74.
29. Schoenicke G, Grabensee B, Plum J. Dialysis with icodextrin interferes with measurement of serum alpha-amylase activity. Nephrol Dial Transplant 2002; 17:1988-92.
30. Bajo MA, Selgas R, Hevia C, Castro MJ, Aquilera A, Millan I, et al. Icodextrin 7.5% dialysate for diurnal exchange in patients treated with CCPD [Abstract]. Perit Dial Int 1999; 19(Suppl 1):S49.
31. Grzegorzewska AE, Antczak-Jedrzejczak D, Mariak I. Polyglucose dialysis solution influences serum activity of amylase and of lipase differently. Adv Perit Dial 2000; 16: 113-18.